VESSELON
Vesselon is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as the backbone of its encapsulated drug/drug platform technology. Furthermore, the complexes are formed at the time of administration (rather than at the drug manufacturing stage) enabling the creation of new complexes from already approved therapeutics. The company is developing a next-generation, multi-targeted enca... psulated oncolytic virus complex that has been shown in preclinical models to be effective at low titers across a wide range of tumors. Also, the company is developing an encapsulated recombinant interleukin-2 complex targeting clinically relevant dosages to solid tumors with systemic exposure far below that which could cause adverse events. Vesselon’s proprietary complexes can be applied across a spectrum of cancers and other serious diseases in a variety of drug classes.
VESSELON
Industry:
Biotechnology Health Care Medical Medical Device Oncology
Founded:
2012-01-01
Address:
Norwalk, Connecticut, United States
Country:
United States
Website Url:
http://www.vesselon.com
Total Employee:
1+
Status:
Active
Contact:
(203) 989-0500
Total Funding:
1.01 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API WordPress SSL By Default HSTS ReCAPTCHA Microsoft Exchange Online Office 365 Mail
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Canfel Therapeutics
CanFel Therapeutics is an emerging veterinary oncology company
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Chasing Science
A biomedical venture developing a portfolio of medical solutions focused on oncology and eye diseases.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Runway Healthcare
Runway Healthcare is a MedTech Accelerator investing in early-stage technologies that transform patients’ lives.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Rhodemann Li Founder, EVP Strategy & Finance @ Vesselon
Founder, EVP Strategy & Finance
2014-01-01
Clay Larsen President and CEO, Co-Founder @ Vesselon
President and CEO, Co-Founder
2012-11-01
Neil Edwards Chief Financial Officer @ Vesselon
Chief Financial Officer
2020-12-01
Founder
Investors List
CTNext
CTNext investment in Pre Seed Round - Vesselon
Connecticut Innovations
Connecticut Innovations investment in Pre Seed Round - Vesselon
Official Site Inspections
http://www.vesselon.com
- Host name: 132.172.62.50.host.secureserver.net
- IP address: 50.62.172.132
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Vesselon"
Vesselon
Vesselon develops patentable drug co-formulations using an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes. These co-formulations safely make …See details»
Vesselon - Crunchbase Company Profile & Funding
Vesselon is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as …See details»
Vesselon, Inc. - BioCT
Vesselon, Inc. is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as …See details»
Leadership – Vesselon
Jared Weiss, MD Clinical Research, Thoracic Oncology UNC, Lineberger Cancer CenterSee details»
Vesselon, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Discover how Vesselon is shaping the future of drug development. About Vesselon Inc. Vesselon, Inc. is pioneering the development of patentable drug co-formulations using FDA-approved …See details»
Vesselon Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Vesselon. Use the PitchBook Platform to explore the full profile.See details»
Vesselon - Overview, News & Similar companies | ZoomInfo.com
Aug 27, 2023 · Vesselon, Inc., is developing VEST, a novel therapeutic immuno-oncology complex that protects and targets tumors. VEST stands for Vascular Encapsul.See details»
FAQs – Vesselon
Vesselon CEO and Co-founder Clay Larsen and Epistat CEO Dr. Llew Keltner discuss key Vesselon data indicating the company’s platform can get approx. 4x, or 400% more antibody …See details»
Vesselon Introduces the First On-site Co-Formulation …
Aug 28, 2023 · For drug companies, this system can offset the loss of exclusivity on mature drugs with new patentable co-formulations. Because it combines the drugs on-site, the platform can be adopted seamlessly...See details»
Vesselon - Contacts, Employees, Board Members, Advisors & Alumni
Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.See details»
Neil Edwards - Chief Financial Officer at Vesselon | The …
Neil Edwards joined Vesselon as CFO in December 2019 bringing 30 years of business execution strategy and fund-raising experience to the team. Edwards served in C-suite roles in Interos, VeriSign, infoGroup, and dotMobi over his …See details»
How Vesselon Can Improve the Entire Class of Antibody-Drug
Oct 5, 2023 · Vesselon develops patentable drug co-formulations with a platform consisting of an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes.See details»
VESSELON: Acquires FDA-Approved Lipid Microsphere Drug …
Aug 8, 2019 · Vesselon (www.vesselon.com), an oncology therapeutics company, today announced the acquisition of an FDA-approved drug Imagent®. Vesselon will use Imagent to …See details»
Town Hall – Vesselon
IN THIS VIRTUAL TOWN HALL WITH EXPERTS FROM INDUSTRY, WE: Review the biophysical modes of action that work in concert to change the receive characteristics of tissue …See details»
Overview: Vesselon’s Transformative Co-formulation Method
Jan 15, 2024 · Vesselon develops patentable drug co-formulations using an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes. These co …See details»
Vesselon, Inc. (Vesselon, Inc.) - 药物管线_专利_临床试验_投融营收_ …
Discover how Vesselon is shaping the future of drug development. About Vesselon Inc. Vesselon, Inc. is pioneering the development of patentable drug co-formulations using FDA-approved …See details»
How Vesselon Can Improve the Entire Class of Radiopharmaceuticals
Nov 21, 2023 · Vesselon develops patentable drug co-formulations using an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes. These co …See details»
Technology – Vesselon
Our platform conjugates drugs on site. Consisting of drug encapsulated lipid microspheres, drug encapsulated liposomes and circulating unbound drugs, all in a single injection, our …See details»
How Vesselon Can Improve the Entire Class of Antibody-Drug …
Oct 30, 2023 · Vesselon develops patentable drug co-formulations with a platform consisting of an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes. …See details»
Commercial Maritime Freight Management Platform - Veson …
Veson empowers global maritime organizations and stakeholders to turn complexity into a sustainable decision advantage. Turn maritime risk exposure into measurable reward for your …See details»